Bristol Myers Squibb Statement on Oncologic Drugs Advisory Committee[...]
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public[...]
10/10/2022 | Press release | Distributed by Public on 10/10/2022 15:32
Please select the service you want to use:
Smartlinks | Vale SA | Finance | Security Markets | Derivative Securities | Security Markets | Company News | Investment Funds | Public Companies | Mining and Exploration Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | Bolsa de Comercio de Buenos Aires (BCBA) | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Börse Hamburg | Börse Hannover | Latibex | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Proveedor Integral de Precios (PIP) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact